Dados B3 › DASA3 × HAPV3
DASA3 × HAPV3
Indicators
Each row uses the most recent year in which BOTH companies have the figure, and says which year that is. A cell with ! carries a caveat — hover to read it. We do not name a winner: that would be a recommendation, and this site does not give any.
| indicator | DASA3 | HAPV3 | year |
|---|---|---|---|
| ROE | -15.6% | -0.3% | 2025 |
| ROIC | 4.2%! | 1.8%! | 2025 |
| ROA | -5.0% | -0.2% | 2025 |
| Gross margin | 30.4% | 11.8% | 2025 |
| EBIT margin | 8.1% | 4.6% | 2025 |
| Net margin | -10.2% | -0.5% | 2025 |
| Net debt/EBITDA | 2.45x | 1.66x | 2025 |
| Current ratio | 1.24x | 1.90x | 2025 |
| Revenue growth (1y) | -27.1% | 9.2% | 2025 |
| Revenue growth (5y CAGR) | 9.7% | 29.8% | 2025 |
| Piotroski F-Score | 4/9 | 6/9 | 2025 |
Point-in-time multiples
Priced at the first session on or after the day each filing became public — never the period close.
| indicator | DASA3 | HAPV3 | year |
|---|---|---|---|
| P/E | -3.70x | -27.50x | 2025 |
| P/B | 0.62x | 0.08x | 2025 |
| EV/EBITDA | 4.56x | 2.95x | 2025 |
| FCF yield | -7.7% | 26.2% | 2025 |
Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 11:22 UTC. If this does not match /saude, you are reading a cached copy.
Sources: CVM (open data, ODbL) and B3 (COTAHIST). Not affiliated with B3 or the CVM. Not investment advice.
Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 11:22 UTC. If this does not match /saude, you are reading a cached copy.